InClin, Inc.

InClin is a full-service Contract Research Organization (CRO) founded in 1998 that provides comprehensive clinical development services to pharmaceutical, biotechnology, and medical device companies. The company supports clinical trials from Phase 1 through Phase 4, offering an integrated suite of services including project management, clinical monitoring, biostatistics, data management, medical writing, drug safety, and strategic consulting. Headquartered in San Mateo, California, with a significant presence in Sydney, Australia, InClin emphasizes a collaborative, sponsor-centered approach to clinical research. The organization has managed hundreds of clinical trials and contributed to multiple regulatory approvals, including NDAs and BLAs, across a wide range of therapeutic areas such as oncology, neurology, cardiovascular health, and rare diseases.